Brady Corporation. (NYSE:BRC) Q4 2019 Results Earnings Conference Call September 6, 2019 10:30 AM ET
Ann Thornton - CAO & Corporate Controller
Michael Nauman - President and Chief Executive Officer
Aaron Pearce - Chief Executive Officer and Treasurer
- Ann Thornton - CAO和公司财务总监
- Michael Nauman - 总裁兼首席执行官
- Aaron Pearce - 首席执行官兼财务主管
Molly Baum - Bank of America Merrill Lynch
Allison Poliniak - Wells Fargo
Joe Mondillo - Sidoti & Company
Keith Housum - Northcoast Research
- Molly Baum - 美国银行美林
- Allison Poliniak - 富国银行
- Joe Mondillo - Sidoti＆Company
- Keith Housum - Northcoast Research
Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2019 Brady Corporation Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question and answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference may be recorded.
I would now like to turn the call over to Ann Thornton, Chief Accounting Officer. You may begin.
美好的一天，女士们，先生们，欢迎参加2019年第四季度布雷迪公司收益电话会议。 此时，所有参与者都处于只听模式。 稍后我们将进行问答环节，并在那时给出指示。 [操作员说明]提醒一下，可以记录此会议。
我现在想把这个电话转给首席会计官Ann Thornton。 你可以开始吧。
Thank you. Good morning and welcome to the Brady Corporation fiscal 2019 fourth quarter earnings conference call. The slides for this morning's call are located on our website at www.bradycorp.com/investors.
We will begin our prepared remarks on slide number three. Please note that during this call, we may make comments about forward-looking information. Words such as expect, will, may, believe, forecast and anticipate are just a few examples of words identifying a forward-looking statement. It's important to note that forward-looking information is subject to various risk factors and uncertainties, which could significantly impact expected results. Risk factors were noted in our news release this morning and in Brady's fiscal 2019 Form 10-K, which was filed with the SEC this morning as well. Also, please note that this teleconference is copyrighted by Brady Corporation and may not be rebroadcast without the consent of Brady. We will be recording this call and broadcasting it on the Internet. As such, your participation in the Q&A session will constitute your consent to being recorded.
I'll now turn the call over to Brady's President and Chief Executive Officer, Michael Nauman.
Thank you, Ann. Good morning and thank you all for joining us. This morning we released our 2019 fourth quarter financial results. We have a lot to be proud of this year. We continue to improve our manufacturing processes, we rebuilt our new pipeline to our focused investment in R&D and we’re driving operational efficiencies throughout our organization. All of this has resulted in increased organic sales, reduced SG&A expenses and increased profits.
This quarter marks our ninth straight quarter of organic sales growth which was driven by our focus on new product development and consistent execution of our strategy. We sold the business during last year’s fourth quarter and recognized a gain of $4.7 million on that sale.
When we exclude this one-time gain, pretax income increased 16% which marks our 16th consecutive quarter of profit improvement. I’m incredibly proud of the entire team at Brady for hitting this milestone. The ability to improve quarterly pre-tax profit for three years takes a great deal of focus on our consistent set of priorities, which are to develop and deliver innovative new products that solve our customer's problems to drive operational efficiencies throughout our business to improve the businesses that are not performing as well as they should be and most importantly, to ensure that the actions we take today are the right decisions for the long term.
Organic sales growth of 1.7% was driven by our Identification Solutions business, which posted organic sales growth of 3.3% this quarter, the strongest growth continues to come from the U.S. we're growing in most end markets and almost every major product line. We've launched some exciting new products this quarter and I'm pleased to report that our health care product line grew organic sales in the mid-single digits this quarter.
Our investments in the sales force and R&D in the healthcare product line are beginning to pay off as we improve both organic sales and profit this quarter. Organic sales declined 2.6% in WPS this quarter. Our North American WPS business showed improvement as its rate of decline decreased from approximately 10% last quarter to mid-single digit decline this quarter.
During our last two quarterly conference calls, we discussed how we took actions to enhance our digital platform by moving to a new platform, this new platform is working well and our digital sales are improving, but we still see, will take time to build our customer base back to the level we experienced prior to the initial digital platform change.
We believe that we're on the right track to return the WPS America's business profitable growth. There are positive trends with this business in the quarter, as May was our toughest sales month and we saw improvements in June, and then again in July. With the fundamental building blocks for sustainable organic sales growth in place, we're looking ahead to what we believe will be the start of a trend of organic sales and profit improvements in fiscal 2020.
We've made incredible progress, four straight years of quarterly pretax income improvement is not easy, but the Brady team took on the challenge and delivered. I see more energy and drive in our people than ever before. We've returned our healthcare business to growth and we've taken actions in our workplace safety business that will set us up for future success.
The industrial economy is challenging, but we believe that the actions we've been taking over the last several years to invest in our organic sales engine and drive sustainable efficiency gains to reduce our cost structure position us well for future revenue and profit growth. We continue to focus on the future by taking action today that will ensure our success in the long term.
I'll now turn the call over to Aaron to discuss our financial results. I'll then return to provide specific commentary about our identification solutions, and workplace safety businesses. Aaron?
我们取得了令人难以置信的进步，连续四年的季度税前收入改善并不容易，但布雷迪团队接受了挑战并交付了。 我比以往任何时候都看到更多精力和动力。 我们已经将我们的医疗保健业务恢复增长，并且我们已经在我们的工作场所安全业务中采取行动，这将为我们未来的成功奠定基础。
Thank you, Michael. And good morning, everyone. The financial review starts on slide number three. Sales were $295.3 million in the fourth quarter, which consisted of organic sales growth of 1.7% a decrease of 1.9% from foreign currency translation, and a decrease of 0.5% from the sale of our Runelandhs business which we finalized in the fourth quarter of last year.
Net income finished at $36.6 million compared to $35 million in last year's fourth quarter. If you would exclude last year's onetime gain on the sale of a business, net income would have increased by 20.9%.
Diluted EPS was $0.68 this quarter, compared to $0.66 in last year's fourth quarter. The sale of Runelandhs increased the EPS by $0.09 per share last year, so excluding this onetime gain from last year, diluted EPS increased 19.3% this quarter.
Cash generation, which is a hallmark of Brady and a never ending focus area, continues to be strong. Cash flow from operating activities were $65.3 million this quarter compared to $53.8 million in the fourth quarter of last year, an increase of more than 20%.
On slide number four, you'll find our quarterly sales trends. Our Identification Solutions business continues to grow nicely with organic sales growth of 3.3% while our WPS business experienced an organic sales decline of 2.6% this quarter.
Turning to slide number five, you'll find our gross profit margin trending. Our gross profit margin was 49.6% this quarter, which was consistent with last year's fourth quarter. We continue to see cost pressure in both IDS and WPS, but we've been successful in offsetting these increases through selected price increases and our constant focus on process improvements, and manufacturing efficiencies across all of our facilities.
Slide number six outlines our SG&A expense trending. SG&A was $89.1 million this quarter compared to $90.9 million last quarter. Last year’s SG&A was reduced by the $4.7 million gain on the sale of a business. If we exclude this gain, we would have reported a decrease in SG&A of $6.5 million this quarter.
Approximately, one third of this decrease was due to foreign currency translation, as the U.S. dollar strengthened against most major currencies and the other two thirds of the decrease was due to our ongoing efforts to drive process improvements and efficiency gains throughout our businesses. Excluding the onetime gain in the fourth quarter of last year, SG&A expense decreased from 32.1% of sales in last year's fourth quarter to 30.2% of sales this quarter.
Turning to slide number seven, you'll find the trending of our investments in research and development, which decreased from $11.7 million in the fourth quarter of last year to $11.3 million this quarter.
Excluding the impact of foreign currency, R&D expenses were effectively flat for the full fiscal year 2019 compared to last year. We remain committed to new product development while at the same time, we're focused on making disciplined investment decisions to ensure that our R&D spend is efficient and effective.
Slide number eight outlines the quarterly trending of pretax income. Excluding the gain on the sale of a business from last year's fourth quarter, we increased pretax income by 16% to $47.1 million compared to $40.6 million last year. This is an indication that our focus on organic sales growth and driving sustainable efficiency gains is working.
Turning to slide number nine, you'll find our after tax income trends and our quarterly EPS trends. The sale of our Runelandhs business in last year's fourth quarter added $0.09 to diluted EPS, adjusting for this onetime gain diluted EPS increased from $0.57 last year to $0.68 this year, an increase of 19.3%.
Slide number 10 details our quarterly cash generation. We generated $65.3 million of cash flow from operating activities compared to $53.8 million in last year's fourth quarter. And free cash flow was $50 million compared to $46.8 million in the same quarter of last year.
We continue to generate cash flow in excess of net income and for the full fiscal year, cash flow from operating activities was 124% of net income. We also returned $11.2 million to our shareholders in the form of dividends this quarter, and we invested $15.3 million in capital expenditures.
This quarter's CapEx was larger than normal as we've been actively upgrading our machinery and equipment to both add more capabilities, as well as to drive efficiencies and increase productivity. This quarter, we also completed the purchase or moved forward with the construction of several manufacturing facilities that we've historically leased. These are manufacturing facilities we intend to be in for the long term and where it makes financial sense to own instead of lease.
Slide number 11 outlines the trending of our net cash position along with our debt structure at the end of the quarter. We increased our net cash position by $100 million this year, while increasing our investment in capital expenditures and increasing our dividends, which again highlights our ability to consistently generate strong cash flow.
We finished the year in a net cash position of $228.9 million on July 31st. Our debt consists of a $45 million euro denominated private placements scheduled for repayment in May of next year, and we have no borrowings outstanding on our recently renewed line of credit.
Our approach to capital allocation is consistent with disciplined and we are patient. First, we use our cash to fund organic sales and efficiency opportunities throughout the economic cycle, which includes funding investments in new product development, sales generating resources, IT improvements, capability enhancing capital expenditures, and capital expenditures to increase efficiency and automation in our facilities.
And second, we focus on returning cash to our shareholders in the form of dividends. In fact yesterday, we announced our 34th consecutive year of annual dividend increases, as we increased our full year dividend to $0.87 per share.
After funding organic investments and dividends, we then deploy our cash in a disciplined manner for acquisitions where we believe we have strong synergistic opportunities and we use our cash to improve shareholder returns through opportunistic share repurchases.
Overall, our cash generation is strong. Our balance sheet is strong, and we're focused on driving long value for our shareholders through the disciplined allocation of capital. Before moving to our fiscal 2020 EPS guidance, let's take a look back at our financial results for the full fiscal year 2019, which is on slide number 12.
This year, we increased organic sales in each quarter and grew 2.8% organically for the full year. We increased our GAAP pre-tax income by 8.3% and if you exclude the gain we recorded from the sale of Runelandhs business, then our pretax profit grew by 11.7%.
We returned the health care product line of our Identification Solutions business to organic growth. We took actions to address the cost structure of our WPS North America business, and we expect to see the benefits next year from the digital platform change and cost structure realignment.
We recorded a healthy gross profit margin of 49.9% and we remain focused on executing sustainable process improvements, which is evidenced in our SG&A expense was decreased to $19.3 million this year, increased -- decreased by $19.3 million this year, marking the fourth consecutive quarter of decrease to SG&A expense as a percent of sales.
We generated $162.2 million of cash flow from operating activities, which equates to approximately 124% of net income. This strong cash generation also led to our non-operating income and expense items turning from a net expense in fiscal 2018 to a net benefit of $2.2 million in fiscal 2019 due to reduced borrowing costs, as well as increased investment earnings as a result of our strong balance sheet.
Our fiscal 2019 results were strong and our balance sheet is strong. We are seeing weakness in the global industrial economy, but we believe that the actions we've taken to improve our WPS Americas business to return our health care product line to growth and to drive sustainable growth in all of our businesses through an increased focus on innovation will enable us to maintain our positive momentum into fiscal 2020.
We believe, we're taking the right actions today to ensure our long term success. But as always, execution remains critical, which brings us to our fiscal 2020 guidance, which is summarized on slide number 13.
We expect earnings per diluted Class A Nonvoting common share to range from $2.45 to $2.55 for the fiscal year end in July 31st 2020. Our EPS growth will be driven by organic sales growth of approximately 1.5% to 2.5%, along with continued efficiency gains in both our manufacturing facilities and our SG&A structure. We expect our income tax rate to be in the low 20% range. Depreciation and amortization expense to approximate $25 million, and we anticipate capital expenditures of approximately $35 million.
We also expect to continue to realize non-operating income in excess of interest expense as a result of our strong balance sheet. This guidance is based on foreign currency exchange rates as of July 31st which continue to be a headwind due to the strength of the U.S. dollar.
我们录得49.9％的健康毛利率，并且我们仍然专注于执行可持续的流程改进，这证明我们的SG＆A费用今年减少至1,930万美元，增加 - 今年减少了1,930万美元，连续第四个季度减少SG＆A费用占销售额的百分比。
We're not anticipating any restructuring charges, and we're not excluding any one time income or expense items from this guidance. This guidance is based on financial results that are fully in accordance with U.S. GAAP.
I'll now turn the call back over to Michael to cover our divisional results, and to provide some closing comments, before turning the call over to Q&A. Michael?
Thank you, Aaron. Slide number 14 summarizes the fourth quarter financial results prior for our Identification Solutions business. IDS sales increased 1.8% finishing at $221.8 million with organic sales growth of 3.3% while foreign currency translation decreased sales by 1.5% this quarter.
Organic sales increased in the low single digits in all three regions. They also increased organically in the majority of our key product lines, but the strongest growth in safety and facility identification.
As I mentioned earlier, I'm pleased to report that our healthcare identification product line increased organic sales in the mid-single digits this quarter. The additions we've made to our sales force as well as the products we've added to our new product pipeline are starting to result in organic sales growth and profit improvements.
We finished fiscal 2019 with positive momentum that will carry into next year. Organic sales increased in the low single digits in IDS Europe this quarter. We're increasing sales in most major product lines in Europe, but we believe there's been an overall reduction in the industrial economy, which caused our growth rate to slow from mid-single digits last quarter across most geographies and product lines to the low single digit rate, we saw this quarter.
In Asia, we experienced low single digit organic sales growth even though we've clearly seen a decrease in demand in certain end markets, such as electronics in China, and automotive in India. In general, our growth rates have slowed throughout Asia and there appears to be economic weakness in China, which is our largest Asian market.
IDS segment profit increased 25% to $45.6 million in the fourth quarter compared to the fourth quarter of last year. As a percentage of sales, segment profit improved to 20.6% this quarter compared to 16.8% last year.
Our improved financial performance continues to be due to a combination of successfully driving organic sales growth, or at the same time driving efficiencies throughout our businesses. We've launched several new products in our IDS businesses year quarter. We launched the battery block -- battery cable lock out device which is part of our lock out, tag out product line. This is a simple, but effective device that is designed to be secured around the battery connection or electrical system of a commercial vehicle, while performing maintenance, which prevents an accidental battery connection that could endanger the safety of the mechanic, or cause other damage to the vehicle. We also launched a similar product that is designed to lock out the battery connection on forklifts.
We also launched two new printer models in our healthcare product line this quarter. The first is a service [ph] desktop printer, which is a high speed, patient wristband printer, that's easy to use and fully integrated with electronic medical record software. The second is the Portico mobile printer, which is Wi-Fi and Bluetooth enabled, and allows medical professionals to print bar-coded labels on the spot at the point-of-care of the patient. I'm excited about the addition of these printers to our healthcare product line, and our expanded pipeline of new products. It's a direct result of the increased investment in R&D that we've made over the past several years.
我们改善的财务业绩继续归功于成功推动有机销售增长，或同时提高整个业务的效率。我们在本季度的IDS业务中推出了几款新产品。我们推出了电池块 - 电池电缆锁定装置，这是我们锁定，标记产品线的一部分。这是一种简单但有效的设备，旨在固定在商用车的电池连接或电气系统周围，同时进行维护，防止意外的电池连接，可能危及机械师的安全，或造成其他损害机动车。我们还推出了一种类似的产品，旨在锁定叉车上的电池连接。
Looking ahead to fiscal 2020, we expect IDS organic sales to grow between 2% and 3%. We'll continue to invest in R&D and we'll continue to drive efficiencies throughout our manufacturing and SG&A processes. We believe that F-20 will be a challenging macroeconomic environment for global manufacturers, but we're confident that the changes we've put in place will enable us to grow -- continue to grow above GDP.
Turning to slide number 15, you'll find our workplace safety review. WPS sales declined 7.8% which consists of organic sales declines of 2.6% an increase from foreign currency of 3.3% and a decrease from the divestiture of Runelandhs business of 1.9% compared to the fourth quarter of last year.
Organic sales declined in the low single digits in European and Australia businesses, and organic sales declined in the mid-single digits in the North American business. As we discussed in previous calls this year, we've made a change to our digital platform in the U.S. business and we're now seeing consistent improvements in our digital sales. But it will still take more time for us to build sales back to the level we experienced prior to the initial platform change.
We remain focused on three priorities to return WPS Americas business to consistent organic sales growth. First, we're improving the buying experience for our customers so that it's as simple as possible; reach out to customers the way they prefer to be reached, whether it's online, mobile, catalog, in-person or through a combination of these channels is essential to returning this business to growth which is exactly why we're focusing on having industry leading websites.
Second, we're increasing our customer interactions rather than only fulfilling orders. This allows us to better understand what our customers are dealing with from a safety and identification perspective, and it helps us better serve those needs by offering our compliance expertise and complete solutions. We're just doing this to an expanded sales force that is capable of providing full solutions for our customers, that is also grounded in industry knowledge and regulatory expertise that our competitors do not possess.
Third, one of our strengths is our ability to customize product and quickly turn orders. We've improved our portfolio of products by introducing more customized and proprietary products that our customers need. We believe, we're increasing the value that we bring to our customers by focusing on these three priorities, which creates customer loyalty and improves our sales and profitability over the long term. We believe, we're taking the right action to return our North American business to sustainable organic sales and profit growth.
A recovery has been and will continue to be choppy. Our sales declined at a lesser rate this quarter than in the third quarter, although -- but they still declined. We need to stop the decline in sales and then return the business to growth. We believe, we're on the right track as we finish this fiscal year and move into 2020.
展望2020财年，我们预计IDS有机销售额将增长2％至3％。我们将继续投资研发，并将继续提高整个制造和SG＆A流程的效率。我们认为F-20将成为全球制造商具有挑战性的宏观经济环境，但我们相信，我们实施的变革将使我们能够实现增长 - 继续高于GDP增长。
Our European WPS business declined organically in the slowest low single digits this quarter, but sales growth steadily improved through the quarter and we closed July on a positive note. Digital sales continue to be strong in Europe where we saw growth in the mid-single digits but this quarter that growth wasn't enough to fully offset the decline in catalog sales.
Organic sales decline in the low single digits in Australia this quarter. We had been growing steadily for the past couple of years, but more recently the growth rate in the Australian economy appears to have slowed. We were still able to improve profit in Australia this quarter despite the modest sales decline. This profit improvement was entirely due to our focus on driving sustainable, operational, efficiencies.
WPS segment profit was $6.7 million compared to $10.7 million in last year's fourth quarter. The decline in segment profit was due to organic sales decline, foreign currency translations and the sale of the Runelandhs business which closed on May 31st 2018. For the full fiscal 2020, we expect organic sales to be approximately flat in the WPS business, and we expect improvement segment profit through our reduced cost structure and through continued efficiencies in SG&A.
As I look back at this year, I'm proud of what we've accomplished. We're growing organic sales. We're launching innovative new products. We're executing efficiency opportunities throughout our SG&A structure. We will turn to healthcare product line to grow, and we're on our way to turning our WPS North American business around.
Our IDS business is strong, and continues to lead our consistent improving financial results, and WPS Europe and Australia are executing their digital strategies, and growing their online presence, while driving efficiencies throughout their businesses.
This quarter, marks my completion of five years with Brady. As I look back, I'm proud of the progress we've made not only through improved financial results, but as an organization, or committed to providing our customers with high quality products that meet their needs and solve their problems with responsive customer service, and ongoing sales support.
I regularly challenge our employees to get closer to the customer and think about how they're supporting this fundamental initiative, which at its core is simply focused on what we do well. This results in consistent growth in organic sales and significant profit improvement over the past four years, and has made us a more effective and efficient organization that is better able to react and adapt to change.
Labor continues to be a competitive situation especially in certain locations where the unemployment rate is historically low. Because of this we're challenging ourselves to think differently, to take our processes to the next level of automation, to use our IT systems more effectively. This reduces our need for resources, that are already scarce. Innovation is not only relevant to our new product development teams being innovative about what we do and how we do it has been a primary driver of our ability to drive four straight years of pretax profit improvement. It takes the entire organization -- working towards a common goal to deliver this level of consistent financial improvement. I'm proud of the team for eliminating distractions and making themselves accountable for our results.
劳动力继续处于竞争状态，特别是在失业率处于历史低位的某些地区。因此，我们挑战自己，以不同的方式思考，将我们的流程提升到更高的自动化水平，更有效地使用我们的IT系统。这减少了我们对资源的需求，这些资源已经很少。创新不仅与我们的新产品开发团队相关，我们的工作创新以及我们的工作方式也是我们连续四年提高税前利润的主要动力。它需要整个组织 - 努力实现共同目标，以实现这种一致的财务改进。我为团队消除分心并使我们对结果负责而感到自豪。
I'd like to start the Q&A. Operator, would you please provide instructions to our listeners.
Thank you. [Operator Instructions] Our first question comes from George Staphos of Bank of America Merrill Lynch. Your line is now open.
谢谢。 [操作员说明]我们的第一个问题来自美国银行美林公司的George Staphos。 你的生产线现已开放。
Hi. This is actually Molly Baum sitting on for George. Congrats on the quarter. I just wanted to start by asking a quick question about margins in IDS. You mentioned process improvement and efficiency gain. Sorry. But can you provide more detail on maybe some of the specific actions that you've been taking that have really driven such strong incremental margin in the second and particularly in your fiscal fourth quarter. Thank you.
你好。 这实际上是莫莉鲍姆坐在乔治。 祝贺本季度。 我只是想问一下关于IDS利润的快速问题。 您提到了流程改进和效率提升。 抱歉。 但是，您是否可以提供更多详细信息，说明您在第二季度尤其是第四季度确实推动了如此强劲的增量利润的一些具体行动。 谢谢。
Thank you, Molly. Glad to have you on the call this morning. As we take a look at our portfolio, we have really focused strongly on not only making our products relevant to our customers as we go forward, but also making sure our factories in particular are an avenue for us to provide a very positive customer experience.
And that starts with making sure we get the products out faster to the customer. By doing that, it inherently has us looking at automation, more EDI interfacing, direct communications between our software and our machinery and therefore having the right machinery to be able to do all of that. That has been coming through this quarter as you can see, and we have more projects on the road in the future but it's definitely had a significant impact.
莫莉，谢谢你。 很高兴今天早上有你的电话。 在我们看看我们的产品组合时，我们非常注重不仅在我们前进的过程中使我们的产品与客户相关，而且还确保我们的工厂特别为我们提供非常积极的客户体验。
首先要确保我们能够更快地将产品送到客户手中。 通过这样做，它固有地让我们看到自动化，更多的EDI接口，我们的软件和我们的机器之间的直接通信，因此拥有能够完成所有这些的正确机制。 你可以看到，这个季度已经到了这个季度，我们将来会有更多的项目，但它肯定会产生重大影响。
Thank you for that. And then, my second question. You mentioned, some slides following in IDS in both Europe and Asia. Can you talk about, how those two regions trended through the quarter. And when we're looking at you know guidance for the segment that organic growth of 2 to 3 percent what are your assumptions for how each region as you expect it to trend for the year? Thank you.
谢谢你。 然后，我的第二个问题。 你提到过，在欧洲和亚洲的IDS中都有一些幻灯片。 你能谈谈这两个地区在整个季度的趋势吗？ 当我们看到您时，您知道该细分市场的指导意见，即有机增长率为2％至3％，您对每个地区的假设是如何预期的那样？ 谢谢。
So obviously, there are a lot of dynamic issues going on in Asia, particularly in China. If I had a crystal ball, I would give it to you. I think there are a lot of pieces in action there. We will hope for the best in our trade negotiations throughout the world. But at the same time we are prepared to make sure we're the most efficient and effective supplier. And as you've seen, I think we've held up pretty well in Asia and China despite the headwinds that we've seen. We are, as an organization planning for further headwinds, but I don't think that it's been getting significantly worse. I think, it's just a challenging environment.
Now if we flip to Europe on the other hand, we've got a lot of pieces moving there. Some of those pieces are once again related to the situation in Asia. If you take a look at countries like Germany where they export a ton of machinery and equipment, and they are the backbone of the industrial heartland of Europe, you will -- you'll see that that economy is struggling mightily right now. And as a result, that is having an impact on our business. And we see that will continue to have an impact.
At the same time, we've got the Brexit situation there. The outcome, once again is unknown and uncertainty often drives for market challenges and that situation has been deteriorating in the U.K. but also it has a great effect on Europe. As an example, if you take out U.K. from the EU, they are literally a major trading partner with Germany once again as an example.
So those situations, Italy is seeing some issues and even France is having some issues creates a dynamic, where we've actually been doing a good job I believe, our teams they're very proud with the introductions of our new products, with really getting to our customers faster and really interacting with them more have been able to overcome those headwinds, but I don't see that changing in the next quarter.
现在，如果我们转向欧洲，我们已经有很多东西在那里移动。其中一些作品再次与亚洲的情况有关。如果你看一下像德国这样出口大量机械设备的国家，他们是欧洲工业中心地带的支柱，你会 - 你会发现这个经济现在正在大力挣扎。结果，这对我们的业务产生了影响。我们认为这将继续产生影响。
Thank You. I’ll turn it over.
Thank you. And our next question comes from Allison Poliniak of Wells Fargo. Your line is now open.
谢谢。 我们的下一个问题来自富国银行的Allison Poliniak。 你的生产线现已开放。
Hi guys. Good morning.
Good morning, Allison.
I just want to test a new product. You know, you mentioned quite -- in a quite a few of your remarks, new products benefiting organic growth. You've obviously been putting a lot of effort into R&D. Is there any way to help us quantify or directionally what that benefit is, Is it a point of growth, is it growth above market? Just any color, there?
我只是想测试一个新产品。 你知道，你提到的很多 - 在你的一些评论中，新产品有利于有机增长。 你显然在研发方面付出了很多努力。 有没有什么方法可以帮助我们量化或定向地获得什么样的好处，它是增长点，还是增长高于市场？ 那有什么颜色吗？
So Allison, I will say what you should see is specifically what we mentioned you know two new printers in our healthcare space. Those figures are a significant move forward. As you know we made an acquisition a number of years ago in healthcare and we've now really positioned ourselves to integrate the capabilities that I think have been hoped for with the capabilities Brady has. And so yes, that is making a significant difference. We don't quantify the actual breakouts and the reason for that is, as you know we have so many segments and so many different product lines that it varies by the product line and the investments we're making.
But we are making broad investments. We've talked about lock out tag out with you. We've talked about our capabilities for wire marketing they've been improving. We've talked about our wrapping capabilities, automated wrapping capabilities and now we’re talking about integrating printers into our health care space. So we do see internally, a product-by-product changes to our growth rates as a fact. But we don't break that out.
Got it. And then just R&D another on there you know entering 2020. Is the fiscal 19 a good run rate from a dollar amount, that we should be thinking about for 2020, or is that going to go up again?
You know expected to go up a little, we are being challenged in that area as in all areas with the tightening market. We are not seeing significant turnover. We really do believe we are a great place to work, a great place to have a career and challenge yourselves in a positive way. So we think that has a big impact on the longevity of our workforce.
But at the same time, when we are looking to fill roles, it is -- it is a little more challenging. All of that said, yes, we do expect to increase our R&D specifically key talent strengths that we want to work on.
你知道预计会有所上升，我们在这个领域受到挑战，就像市场紧缩的所有领域一样。 我们没有看到重大的营业额。 我们确实相信我们是一个理想的工作场所，是一个有事业的好地方，并以积极的方式挑战自己。 因此，我们认为这会对员工的长寿产生重大影响。
但与此同时，当我们想要填补角色时，它是 - 它更具挑战性。 所有这些都说，是的，我们确实希望增加我们的研发，特别是我们想要开展的关键人才优势。
Got it. So should we be thinking at sort of keeping that 4% of sales this range, just under that?
Yes, you can certainly.
Perfect. Thank you.
Thank you. And our next question comes from Joe Mondillo of Sidoti & Company. Your line is now open.
谢谢。 我们的下一个问题来自Sidoti＆Company的Joe Mondillo。 你的生产线现已开放。
Hi, good morning everyone.
Good morning, Joe.
Just on IDS on the quarter itself, just wondering as far as with all these new products that are coming out and as I understand, I think a lot of these are much more value add, higher margin. So I imagine sort of product mix and just the higher volumes itself is definitely driving volume. I'm just wondering how much is that driving the operating margin growth that we saw, because operating margin growth was actually slowing on a year-over-year basis in the first three quarters. And then it really accelerated strong in the fourth quarter. So how much is it based on that, versus operational, productivity improvements?
就本季度的IDS而言，只是想知道所有这些新产品即将推出，据我了解，我认为其中很多都是增值，更高的利润。 所以我想象一下产品组合，只是更高的产量本身肯定会推动产量。 我只是想知道推动经营利润率增长有多大，因为前三季度经营利润率增长实际上同比放缓。 然后它在第四季度真的加速了。 那么，基于此，与运营，生产力改进相比，它有多少？
Joe, if we take a look, because you know we have very good margins on our products. We grew in all core, in all three regions that had an impact. But the biggest impact was out of our healthcare growth, specifically.
乔，如果我们看看，因为你知道我们的产品有很好的利润空间。 我们在所有核心区域都有所发展，这三个区域都产生了影响。 但最大的影响是我们的医疗保健增长，特别是。
Okay. And like I said, the sort of the way, that the year sort of progressed, we saw a huge spike up in the fourth quarter. Can you give us more color exactly what happened in healthcare, what with that those two printers and those added to the sales and the product mix. Well what happened in the fourth quarter and is it sustainable over the next few quarters?
好的。 就像我说的那样，那一年的进展，我们在第四季度看到了巨大的飙升。 您能否为我们提供更多颜色，确切地说是医疗保健中发生的事情，那两台打印机以及那些增加到销售和产品组合中的那些。 那么第四季度发生的事情是否可以在未来几个季度持续下去？
As you -- first of all, it is sustainable. Second, as you recall from previous calls, the healthcare had been our biggest challenge in the IDS space and had not been growing in fact had been declining. We were able to turn that around, and that turn around on a healthy margin business with new types of products that are strong products for our future, has been the most significant fact. I do not want to understate though the growth in all three regions because of the strength of our general margins has had a big impact as well. And we do expect the healthcare part of that to maintain and we do expect the regions to continue to grow. So yes.
正如你 - 首先，它是可持续的。 其次，正如您在之前的调用中所回忆的那样，医疗保健一直是我们在IDS领域面临的最大挑战，并且实际上并没有增长，实际上已经在下降。 我们能够扭转这种局面，并且利用新型产品为我们的未来提供健康的保证金业务，这是最重要的事实。 我不想低估，尽管由于我们的一般利润率的强弱，所有三个地区的增长也产生了很大的影响。 我们确实希望医疗保健部分得以维持，我们确实希望这些地区继续增长。 是的
Okay. And, perfect. Now that definitely I clarified. Thank you. I also wanted to ask regarding these new tariffs that are coming online this fall. Is that going to affect any of your business, do you think?
好的。 并且，完美。 现在我肯定澄清了。 谢谢。 我还想问一下今年秋天即将上线的新关税。 你认为这会影响你的任何业务吗？
We do have business that exports out of China. We also have imports into China. We're a multinational company with 70 plus locations in 31 countries. So those dynamics can be complex. We are working hard to overcome the dynamics. The good news is most of our revenue, because of the type of products we make our local right. The reason we have so many locations and so many even manufacturing locations is to provide local capability and local sourcing to our customer base. It doesn't mean, we won't be impacted in some of our product lines, and we've already had to pass on significant price increases to some of our channel partners and end users. They have accepted those increases, not happily, but they have accepted them, because they understand the reality. We all hope that there is an end to this situation in a positive light for all participants, but we are planning as though that won't change for the foreseeable future.
我们的业务出口到中国以外。 我们也有进口到中国。 我们是一家跨国公司，在31个国家拥有70多个分支机构。 所以这些动态可能很复杂。 我们正在努力克服这种动态。 好消息是我们的大部分收入，因为我们制造本地产品的产品类型。 我们拥有众多地点和众多制造地点的原因是为我们的客户群提供本地能力和本地采购。 这并不意味着，我们不会对我们的某些产品线产生影响，而且我们已经不得不将一些渠道合作伙伴和最终用户的价格大幅提升。 他们已经接受了这些增加，而不是快乐，但他们接受了他们，因为他们了解现实。 我们都希望所有参与者都能以积极的态度结束这种局面，但我们正在计划好在可预见的未来不会改变。
Okay, great. And then last question. The non-operating income doubled for the year, year-over-year compared to last year, and it was higher than I was expecting in the fourth quarter. Just wondering, what is driving that line there? And then in terms of the guidance, I guess for fiscal 20, how do we think about that in terms of the drivers there?
好，太棒了。 然后是最后一个问题。 与去年相比，今年的营业外收入翻了一番，并且高于我在第四季度的预期。 只是想知道，那里的那条线是什么？ 然后就指导而言，我猜在20财年，我们如何根据那里的车手来考虑这个问题？
Yes. In the non-operating lines, we basically have interest income and interest expense. Those are by far the two biggest components. Interest expense, as you know it's been relatively consistent because we have the one piece of debt outstanding, which we intend to pay off at the end of May of next year. And interest income has been growing, and it's been growing because of the cash that we have on our balance sheet today. We're in a very enviable balance sheet position. So we anticipate that interest income will continue to be strong unless we deploy it, unless we deploy that capital. So as you look forward, I would definitely anticipate that non-operating items would continue to be positive into F-20.
是。 在非经营线上，我们基本上有利息收入和利息支出。 这是迄今为止最大的两个组成部分。 利息费用，你知道它是相对一致的，因为我们有一笔未偿还的债务，我们打算在明年5月底还清。 利息收入一直在增长，而且由于我们今天在资产负债表上的现金，它一直在增长。 我们处于一个非常令人羡慕的资产负债表位置。 因此，除非我们部署，否则我们预计利息收入将继续保持强劲，除非我们部署该资本。 因此，当你向前看时，我肯定会预计非运营项目会继续对F-20产生积极影响。...
Okay. So that other, that other income line is mainly interest income then?
Okay. All right. Thanks a lot.
好的。 行。 非常感谢。
Thank you. And our next question comes from Keith Housum of Northcoast Research. Your line is now open.
谢谢。 我们的下一个问题来自Northcoast Research的Keith Housum。 你的生产线现已开放。
Good morning guys and congratulations on the turnaround of the healthcare business.
Thank you, Keith good morning.
Good. Absolutely. So in terms of the CapEx investments, if I heard you right, you guys are investing in machinery which is consistent with you guys in the past, but also it may sound like you guys are investing in some new buildings as well. In terms of your progress along that front, are -- are you seeing some of that in the operating in the lower SG&A now in anticipation that we'll continue to see a decline next year as some of the stories come online, and you can get rid of some of these payments and what not?
好。 绝对。 因此，就资本支出的投资而言，如果我听到你的话，那么你们投资的机器在过去与你们一致，但也可能听起来你们也在投资一些新建筑物。 就你在这方面取得的进展而言，你是否看到其中一些在SG＆A较低的运营中，因为我们预计明年我们会继续看到一些故事，因为有些故事已上线，你可以 摆脱一些这些付款，什么不是？
We do as Keith you're aware, it is financially more advantageous for us to own and lease, but the biggest reason for us owning, it really -- we really have a couple of reasons, one, as we build buildings we can customize them for our particular applications. Two, as we go down the road, we are not reluctant to invest properly in those big buildings, because we aren't going to be double hit by landlords, telling us what a terrific new building they have because of our investments. And then three, the actual soft side as this relates to our people.
It is amazing the positive comments I've received from people who have been in buildings that we've leased for 25 years. When they found out, we were buying the building or building a new building and the comment about the commitment of the company and how strong that makes their commitment to the company. It's an interesting dynamic that frankly is even much stronger than I expected, but one that is so positive I pointed out to you. But those are the real reasons, and you're absolutely correct. The financial difference between leasing and owning is real. But that's not really the driver or us doing it. We need the buildings to be able to be configured in the way we want them, when we want them, and we want to make sure that people are treating the buildings in the high quality manner that we expect.
I just have a fundamental belief, that if you are working in and walking into a building that is a well-run, efficient, clean you will end up making a better more effective product. And that's also showing. So there's a lot of -- there's a lot of benefits to this. Just beyond the accounting treatment.
我们像Keith一样知道，我们拥有和租赁在经济上更有利，但我们拥有的最大原因，它确实 - 我们真的有几个原因，一个，因为我们建造的建筑我们可以自定义它们适合我们的特定应用。第二，当我们走在路上时，我们并不愿意在这些大型建筑中进行适当的投资，因为我们不会受到业主的双重打击，告诉我们因为我们的投资，他们拥有多么棒的新建筑。然后是三个，这与我们的人民有关。
我只是有一个基本的信念，如果你正在工作并走进一个运行良好，高效，清洁的建筑物，你最终会制造出更有效的产品。这也表明了。所以有很多 - 这有很多好处。超出会计处理。
Got you. I appreciate that. And can you walk me through I guess your guidance. You know it’s the puts and takes that you guys are thinking about at the midpoint of the EPS range because you are only 2% above where you were for this year, but yeah, it looks like you're SG&A improvements are really you know kind of stepped up especially as you closed out the year. So what's kind of I guess offsetting some of that SG&A guidance, we're not seeing more of the fall to the bottom line.
有你。 我很感激。 你能告诉我我猜你的指导吗？ 你知道这是你们在EPS范围的中点时所考虑的看跌期权，因为你只比你今年的2％高，但是，看起来你是SG＆A改进真的你知道的那种 当你结束这一年时，尤其是加强了 那么我认为有什么能够抵消部分SG＆A指引，我们没有看到更多的下跌到底线。
I can, I can take that question Keith. I mean, as we look at our guidance -- it's the major -- the major components are relatively consistent with what we've talked about in the past. As we look at gross margins, we have very very strong gross margins at nearly 50% as you know. We're not anticipating massive changes in our gross profit margins. And in fact, we're quite happy where we're at. And the efficiencies that we've put in place have been offsetting actually effectively all of the cost increases we saw in the fourth quarter. We do continue to make improvements in SG&A as you saw in the fourth quarter actually as you saw throughout this year and the last two previous years as well.
And Michael mentioned that we will be investing back into R&D as well. So R&D you should expect to see that as an increase in cost next year in addition to R&D when we look at our tax rate, we anticipate that our tax rate would be in the low 20% range this year. So overall, I’d say that one item that I fail to mention is foreign currency. This continues to be a headwind for us as the U.S. dollar just continues to strengthen against most of the major currencies as well.
So the major headwinds if you will versus EPS would be foreign currency continued and our continued investment back into our R&D expense.
我可以，我可以接受基思这个问题。我的意思是，当我们看到我们的指导 - 它是主要的 - 主要组成部分与我们过去所谈论的内容相对一致。在我们看毛利率时，如你所知，我们的毛利率非常强劲，接近50％。我们预计毛利率不会发生巨大变化。事实上，我们很高兴我们所处的位置。我们实施的效率实际上抵消了我们在第四季度看到的所有成本增加。正如您在今年和过去两年中看到的那样，我们确实在第四季度继续对SG＆A进行改进。
Okay. Thanks. And then I guess Michael, last question I have for you. If I think the historical conversations, there's always a kind of thought process that Brady's performance kind of lag the overall macro economy it is by one to two quarters. Is that still a valid assumption? Or you think it's more immediate response to the macro economists?
好的。 谢谢。 然后我想迈克尔，我有你的最后一个问题。 如果我认为历史对话，总有一种思维过程，布拉迪的表现类型落后于整体宏观经济，它是一到两个季度。 这仍然是一个有效的假设吗？ 或者您认为对宏观经济学家的反应更直接？
Well as you know, we don't have a large backlog. But the -- a lot of our industrial products are toward the -- are used in building construction, used for new layout, new spaces. So we do find that the later end of a economic upturn, we tend to do better, that would be absolutely correct. And if you look at our history, we didn't go down as far, during the down last recession, as the overall economy did. And we don't see that situation changing either, because a lot of our products are needed regardless of the revenue stream at the moment. We certainly aren't immune. As you well know, but we do see a little less sharp decline when we have a big recession and we do see a bigger improvement at the end of a cycle. That said, I also believe we have a strategy now for where we're financially deploying ourselves in a very consistent manner that as we come out of a recession I feel fundamentally very good, and I'm not predicting one by the way, so don't take that the wrong way, but we think this way long term because you asked long term, we think that we'll have a ability to grow better than our competition coming out of the recession because of our continuous investment in R&D and our very close effort to contact and deal with our end users.
如你所知，我们没有大量积压。但是 - 我们的很多工业产品都用于建筑施工，用于新的布局，新的空间。所以我们确实发现，经济好转的后期，我们倾向于做得更好，这绝对是正确的。如果你看一下我们的历史，在整个经济衰退期间，在经济衰退期间，我们并未走下坡路。而且我们也没有看到这种情况发生变化，因为无论目前的收入来源如何，我们都需要很多产品。我们当然没有免疫力。众所周知，但是当我们经历严重的经济衰退时，我们确实看到了一个不那么急剧的下降，我们确实看到在一个周期结束时有更大的改善。也就是说，我也相信我们现在有一个战略，就是我们以非常一致的方式在财务上进行部署，当我们走出经济衰退时，我感觉从根本上说非常好，而且我不会预测一个，所以不要采取错误的方式，但我们认为这是长期的，因为你问长期，我们认为我们有能力比经济衰退中的竞争更好，因为我们不断投入研发和我们非常努力地与最终用户联系和交易。
Great. Thank you.
Thank you. And we do have a follow up question of George Staphos of Bank of America Merrill Lynch. Your line is now open
谢谢。 我们确实有美国银行美林的George Staphos的跟进问题。 你的生产线现已开放
Hey, thanks for taking my follow up. The first, just two additional questions. The first one, Can you talk about kind of what you're seeing in terms of the lockout tagout regulatory landscape? I saw an article come up that trade groups are talking up potentially changing, you know potentially some of the current OSHA regulations. So just wanted to know what you're seeing in that sense.
And then the second just to follow up on Joe's question about IDS. Can you just, again. And sorry if I missed this, highlight what the biggest driver of the margin improvement was? Whether it was the mixed benefit from healthcare growth or you know the cost that that you talked about earlier reduction SG&A etcetera? Thank you.
嘿，谢谢你接受我的跟进。 第一个，只是另外两个问题。 第一个，你能谈谈你在锁定标签监管环境方面所看到的那种情况吗？ 我看到一篇文章提到贸易团体正在谈论可能发生变化，你可能知道当前的一些OSHA法规。 所以只是想知道你在这个意义上看到了什么。
然后第二个只是跟进乔关于IDS的问题。 你能再说一遍吗？ 对不起，如果我错过了这一点，请强调利润率改善的最大驱动因素是什么？ 无论是医疗保健增长的混合利益，还是您知道您之前谈到的降低SG＆A等成本？ 谢谢。
Molly. Molly, Absolutely. Let me start with the lockout tagout. We're developing a variety new products in that space both anticipating change and leading the change. We are absolutely a driver in that space and we feel it's fundamentally a great space both for us and our customers. What I challenge our employees with is we make the world a better and safer place every day. And there are darn few companies and people who can say that and the lockout tagout we push our leadership in that area to make sure we're doing an even better job of that. So these things take time, as you are well aware, but we believe that if changes do come about we are well-positioned to handle all of them.
The second question you have relates to our margins. And the biggest element of that was our healthcare growth. Absolutely, followed by our regional growth.
莫莉。 莫莉，绝对。 让我从锁定标记开始。 我们正在该领域开发各种新产品，既要预见变化，又要引领变革。 我们绝对是这个领域的推动者，我们觉得它对我们和客户来说都是一个很好的空间。 我挑战员工的是我们每天让世界变得更美好，更安全。 而且很少有公司和人员可以这么说，而我们在该领域的领导地位，以确保我们在这方面做得更好。 所以这些事情需要时间，你很清楚，但我们相信，如果确实发生了变化，我们就能很好地处理所有这些问题。
你的第二个问题与我们的利润有关。 最重要的因素是我们的医疗保健增长。 当然，我们的区域增长紧随其后。
Thank you. And ladies and gentlemen, this does conclude our question and answer session. I would now like to turn the call back over to Michael Nauman for closing remarks.
谢谢。 女士们，先生们，这确实结束了我们的问答环节。 我现在想把这个电话转回给Michael Nauman，以便结束发言。
Thank you so much. I'd like to leave you with a few concluding comments this morning. We reported another strong year in 2019. We're growing our organic sales while continuing to generate strong gross margins and reduce SG&A expenses. We're investing in capital expenditures in our facilities to upgrade machinery and to improve our level of automation and we're purchasing or building certain critical manufacturing sites, where it is a strategic fit and makes financial sense.
New products launched in 2019 were the results of our increased investment in R&D over the last several years, and we have more exciting products in our pipeline for future development. Our team is motivated, and are motivated to carry this momentum into 2020 and beyond. Even in this tough economic environment, we expect to grow organic sales, drive efficiencies to the organization and grow earnings. I'm proud of what we've accomplished so far and I know that we're making the right decisions today to set us up for to improve, long term financial situation.
As always, if you have questions, please contact us. Thank you all for participating today, and have a great day. Operator, you may disconnect the call.
Ladies and gentlemen, thank you for participating in today's conference. This concludes today's program. You may all disconnect.
女士们，先生们，谢谢你们参加今天的会议。 这就结束了今天的计划。 你可能都断开了。
- 布雷迪 电话会议
- 布雷迪 财务报告
- 老虎证券开户教程 美股8折佣金， 港股免佣金, 如果入金3000美元，额外再赠送5次免佣卡
- 雪盈证券开户教程 开户后 最高可领取1066港币。美股佣金最低0.002美元/股，港股小额免佣，打新手续费全免
- 富途牛牛证券开户教程 开户即可领取1股汇丰，入金达到2万港币即可领取1股腾讯；新股一键认购，最高支持10倍杠杆融资，免新股认购手续费，暗盘交易免佣；
- 华盛通开证券户教程 开通美股或者港股， 享受现金200元,美股8折奖励。
- 微牛证券开户教程 开通后 享有200元现金奖励
- 必贝证券开户教程 开通后 享有280元现金奖励
- 玖富证券开户教程 开通后 最低入金1W港币可以领218元红包
- e投睿开户教程 开通后 可获得25美金奖励